|
Reperfusion Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion.
|
16526316 |
2006 |
|
Anencephaly
|
0.200 |
Biomarker
|
disease |
MGD |
Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping.
|
10774725 |
2000 |
|
Anencephaly
|
0.200 |
Biomarker
|
disease |
MGD |
Regulation of repulsion versus adhesion by different splice forms of an Eph receptor.
|
11089974 |
2000 |
|
Schizophrenia
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
|
Schizophrenia
|
0.120 |
Biomarker
|
disease |
BEFREE |
A recent report has suggested that copy number variations in four genes (GRIK3, EFNA5, AKAP5 and CACNG2) may be associated with schizophrenia.
|
17826036 |
2007 |
|
Schizophrenia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Moldin et al.(1) have identified a cluster of Minnesota Multiphasic Personality Inventory (MMPI) scales that discriminate adolescents at risk for schizophrenia from those not at risk.
|
10408265 |
1999 |
|
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
|
Smoking
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences.
|
30643258 |
2019 |
|
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
|
Physical Activity Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
GWAS identifies 14 loci for device-measured physical activity and sleep duration.
|
30531941 |
2018 |
|
Hippocampal atrophy
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
|
19668339 |
2009 |
|
Hippocampal atrophy
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
|
19668339 |
2009 |
|
Malignant neoplasm of breast
|
0.030 |
Biomarker
|
disease |
BEFREE |
The role of tissue-resident memory T (T<sub>RM</sub>) cells in breast cancer progression has been difficult to study.Savas et al.[1] (Nat.Med.
|
30077643 |
2018 |
|
Cerebrovascular accident
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores: Findings From the ORBIT-AF I and II Registries.
|
30369317 |
2018 |
|
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
The role of tissue-resident memory T (T<sub>RM</sub>) cells in breast cancer progression has been difficult to study.Savas et al.[1] (Nat.Med.
|
30077643 |
2018 |
|
Malignant neoplasm of breast
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
There are major flaws with the analyses in the Vistisen et al (1) cohort study examining if night shift work is a short-term risk factor for breast cancer.
|
27935621 |
2017 |
|
Cerebrovascular accident
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Patients from GARFIELD-AF were less likely to be white (63% vs 89% for ORBIT-AF I and 86% for ORBIT-AF II) or have coronary artery disease (19% vs 36% and 27%), but had similar stroke risk (85% CHA<sub>2</sub>DS<sub>2</sub>-VASc ≥2 vs 91% and 85%) and lower bleeding risk (11% with HAS-BLED ≥3 vs 24% and 15%).
|
29223431 |
2017 |
|
Breast Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
There are major flaws with the analyses in the Vistisen et al (1) cohort study examining if night shift work is a short-term risk factor for breast cancer.
|
27935621 |
2017 |
|
Malignant neoplasm of breast
|
0.030 |
Biomarker
|
disease |
BEFREE |
We profiled a set of 50 fresh frozen (FF) breast cancer samples and assigned class labels according to the signature and method by van 't Veer et al 1 and then profiled 50 matched FFPET samples to test how well the FFPET data predicted the class labels.
|
19638234 |
2009 |
|
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We profiled a set of 50 fresh frozen (FF) breast cancer samples and assigned class labels according to the signature and method by van 't Veer et al 1 and then profiled 50 matched FFPET samples to test how well the FFPET data predicted the class labels.
|
19638234 |
2009 |
|
Cerebrovascular accident
|
0.030 |
Biomarker
|
group |
BEFREE |
For growth-inhibitory molecules, myelin-associated glycoprotein and ephrin A5 are uniquely induced in the aged brain; chondroitin sulfate proteoglycans and oligodendrocyte myelin glycoprotein are induced at earlier time points; and Nogo-A, semaphorin IIIa and NG2 decline in aged vs. young adult after stroke.
|
16782355 |
2006 |
|
Ulcerative Colitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
The beneficial effects of ALA or AL-1 on the most important parameters of UC were reviewed; also, studies were considered separately in mice and rats.
|
30362597 |
2019 |
|
Ulcerative Colitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
In the present study, we aimed to investigate the therapeutic potential of AL-1 against DSS-induced UC in mice and to define its mechanisms of action.
|
31687082 |
2019 |
|
orbit (eye disorders)
|
0.020 |
Biomarker
|
group |
BEFREE |
Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores: Findings From the ORBIT-AF I and II Registries.
|
30369317 |
2018 |